Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Furiex Pharmaceuticals Company Profile

07:19 EDT 25th July 2014 | BioPortfolio

News Articles [74 Associated News Articles listed on BioPortfolio]

INVESTOR ALERT - FURIEX PHARMACEUTICALS, INC.: The Law Offices of Vincent Wong Investigates the Sale of Furiex Pharmaceuticals, Inc. -- FURX

NEW YORK, April 30, 2014 /PRNewswire/ --The Law Offices of Vincent Wong are investigating potential claims against the Board of Directors of Furiex Pharmaceuticals, Inc. (NasdaqGS: FURX) ("Furiex"...

Forest Labs scoops up Furiex Pharma for $1.1 billion

Forest Laboratories and Furiex Pharmaceuticals has entered into a m&a definitive agreement to acquire Furiex for $95 per share, or approximately $1.1 billion in cash. Also up to $30 per share (app...

Forest Labs to buy Furiex in deal worth $1.5B

Forest Laboratories says it will spend as much as $1.5 billion to buy Furiex Pharmaceuticals Inc. in a deal that could give the drugmaker one of the broadest product lines for gastrointestinal treatme...

Harwood Feffer LLP Announces Investigation of Furiex Pharmaceuticals, Inc.

NEW YORK, April 28, 2014 /PRNewswire/ --Harwood Feffer LLP ( is investigating potential claims against the board of directors of Furiex Pharmaceuticals, Inc. ("Furiex" or the "Compan...

Forest gaining 'relevant' GI position with Furiex buy

In fact, Forest president and CEO Brent Saunders consulted closely with Actavis chairman and CEO Paul Bisaro during the final negotiations with Morrisville, North Carolina-based Furiex. But Forest's i...

Actavis Acquires Furiex Pharmaceuticals

Actavis plc announced that its subsidiary Forest Laboratories LLC has successfully completed its acquisition of Furiex Pharmaceuticals Inc.Read more

Forest Labs Bids $1.5 Billion To Acquire Furiex

Forest Laboratories announced that it will spend as much as $1.5 billion in its latest acquisition bid to buy Furiex Pharmaceuticals. Acquiring Furiex would give Forest Labs one of the broadest produc...

Furiex Pharma: What's The Best Plan Of Action?

By Brian Nichols:In the last week, Furiex Pharmaceuticals (FURX) soared 135% after its diarrhea drug proved statistically significant in two Phase 3 trials that enrolled 2,428 patients. As a result, F...

Drugs and Medications [0 Results]


PubMed Articles [0 Results]


Clinical Trials [0 Results]


Companies [3 Associated Companies listed on BioPortfolio]

Furiex Pharmaceuticals, Inc.

Furiex Pharmaceuticals is a drug development collaboration company using innovative clinical development design to accelerate and increase value of partnered drug programs by adva...

Furiex Pharmaceuticals

Forest Laboratories, Inc. and Furiex Pharmaceuticals, Inc.

Forest Laboratories (NYSE: FRX) is a leading, fully integrated, specialty pharmaceutical company largely focused on the United States market. Forest markets a portfolio of branded...

More Information about "Furiex Pharmaceuticals" on BioPortfolio

We have published hundreds of Furiex Pharmaceuticals news stories on BioPortfolio along with dozens of Furiex Pharmaceuticals Clinical Trials and PubMed Articles about Furiex Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Furiex Pharmaceuticals Companies in our database. You can also find out about relevant Furiex Pharmaceuticals Drugs and Medications on this site too.

Search BioPortfolio:

Corporate Database Quicklinks

Searches Linking to this Company Record